This webcast features: Andrew Lowell, Associate Director, Upstream Process Development, KBI Biopharma, Inc.

KBI Biopharma, Inc. has implemented single-use fermentation (SUF) systems that have allowed greater throughput and efficiency in the laboratory, leading to accelerated project timelines to good manufacturing practice (GMP) production.

The single-use fermentation systems address those programs with relatively small material needs while decreasing validation requirements and increasing operational efficiencies. Coupling process design with the SUF equipment capabilities has enabled processes capable of high cell densities and high titers. We have seen advantages in platforming the growth phase of single-use fermentations, with process optimization focused on the production phase of fermentation. By platforming the SUF system, we allow rapid scaling among single-use systems in the laboratory.

We believe that the successes and efficiencies gained with SUF systems outweigh the few challenges encountered during our implementation of these systems. This technology has improved the flexibility of KBI Biopharma, Inc. as a contract research and manufacturing organization to address multiple and diverse programs through our single-use systems.

Watch the recorded webcast below.